Navigation Links
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life

ielded through an online panel that closely reflects the U.S. adult population overall. Physicians were recruited from a list of all board certified gastroenterologists in the U.S. Assuming no sample bias, the margin of error for the sample of 451 UC patients is +/- 5 percent; assuming no sample bias, the margin of error for a sample of 300 (the other surveys) is +/- 6 percent.

For more information about the survey, visit http://www.UCNORMAL.com. For more information on ulcerative colitis, visit http://www.managinguc.com.

About UC

UC is a type of inflammatory bowel disease that produces chronic inflammation and sores or ulcers along the inside of the large intestine. Symptoms may include severe abdominal pain and cramping, frequent and sometimes uncontrollable bloody diarrhea, fatigue and weight loss. This chronic autoimmune disease is typically first diagnosed in people between the ages of 15 to 30 and is estimated to affect nearly 700,000 Americans. According to the National Institutes of Health, about five percent of people with UC will develop colon cancer.

About LIALDA

LIALDA is part of a drug class called aminosalicylates, which contain 5-aminosalicyclic acid (5-ASA). 5-ASA is a well-established drug of choice and often a first-line treatment for UC. LIALDA is indicated for the induction of remission in patients with active, mild to moderate UC. The safety and efficacy of LIALDA have been established for up to eight weeks. LIALDA is the first new formulation in this class to be approved since 2000. LIALDA is the only ulcerative colitis treatment that utilizes MMX(TM) Technology. LIALDA with MMX Technology combines a pH dependent gastro-resistant coating, which delays the release of the medication to the colon (the site of the inflammation in ulcerative colitis), with a tablet core containing mesalamine with hydroph
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
2. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
3. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
4. Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW
5. Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
6. New Survey Finds Troubling Data on American Asthma Sufferers
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinsons Disease
11. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
Post Your Comments:
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs professionals ... where regulations are often strict and legislation is ... a demand for professionals who have a deep ... across a product lifecycle and demonstrate its use ... University of California, Irvine Extension , in partnership ...
(Date:8/31/2015)... 2015  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... Hagerman , Chairman & CEO, and Sean Whelan , ... Mr. Hagerman and Mr. Whelan are scheduled to participate ... Boston on Wednesday, September 9, 2015 at 1:45 ... also scheduled to participate in the Robert W. Baird 2015 ...
(Date:8/31/2015)... Aug. 31, 2015  Qualcomm Incorporated (NASDAQ: ... Qualcomm Life, Inc., is collaborating with Davita ... management solutions powered by Qualcomm Life,s 2net™ Device ... enable continuous care, informed interventions and better management ... Qualcomm Life,s annual Connect 2015 ecosystem ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 2011 First Quarter Total Revenue $565 million, including $36 million ... growth for the combined company, excluding the impact of foreign exchange ... Diastat and Efudex, pro forma organic growth for the combined company ... EPS $0.02; Cash EPS $0.62 Excluding impact from ...
... 9, 2011 Medison and Samsung Electronics jointly announced ... company, a joint partnership between Korea,s leading diagnostic ultrasound ... most technologically-advanced electronics and consumer goods companies, has outlined ... leader in medical device industry. Mr. ...
Cached Medicine Technology:Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 2Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 3Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 4Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 5Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 6Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 7Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 8Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 9Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 10Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 11Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 12Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 13Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results 14Samsung Medison Pledges to Become a World-Class Medical Device Company 2
(Date:8/31/2015)... Lisle, IL (PRWEB) , ... August 31, 2015 , ... ... announce that Firm Partner William Scott has been nominated by his peers to earn ... by less than five percent of attorneys in the state of Illinois. The nomination ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Vice President, Marketing and Corporate Communications. In this capacity, Michael will provide strategic ... is an industry leader in consumer-focused programs that have contributed to the company’s ...
(Date:8/31/2015)... Newton, North Carolina (PRWEB) , ... August 31, 2015 , ... ... Abernethy Laurels on Tuesday, September 1. , “Alive Inside” shadows a social ... nonprofit “MUSIC & MEMORY?.” , “It’s a documentary about bringing music to residents in ...
(Date:8/31/2015)... ... August 31, 2015 , ... David L. ... was one of the first doctors in the area to perform minimally invasive ... have been impressive: faster recovery, decreased immediate and long-term pain, and an accelerated ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... With the FCPX LUT Soft pack from ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. The ... comes with 60 soft CUBE LUT files. , FCPX LUT Soft requires Final Cut ...
Breaking Medicine News(10 mins):Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2
... Leading patient safety software company to team up ... CAMBRIDGE, MA, Aug. 19 /PRNewswire/ - rL Solutions, the leading ... it will become the founding Corporate Alliance Sponsor of the ... Association. , As part of the partnership, rL Solutions will ...
... , SOMERSET, N.J., Aug. 19 The Tic ... Care (R), it will try to break the Guinness World Record(TM) in ... for charity. Cancer C are is a national nonprofit ... , , Starting today at 11 a.m. ET, individuals ...
... ... a successful strategic workforce planning process,” stated Jim Sirbasku, co-founder and CEO of Profiles ... provides guidelines for implementing each of those 6 components.” , ... Waco, TX (PRWEB) August 19, 2009 -- ...
... ... LLP is urging the manufacturers of the fentanyl or Duragesic pain patches ... potentially fatal overdose. Because of its high potency, patients who receive too much ... a fentanyl overdose. Watson Pharmaceuticals recalled one lot of its fentanyl patches on ...
... ... a group of dentists emphasizing the urgent need for dentists to screen patients for snoring ... , ... Dr. Laurence Barsh recently spoke at the first annual Somnomed Symposium in Oahu, HI to ...
... allows physicians to evaluate suspicious lesions using a variety ... information can help significantly in distinguishing benign from malignant ... published in the September issue of the American ... the study, performed at the University of Washington Medical ...
Cached Medicine News:Health News:rL Solutions to Become the Founding Corporate Alliance Sponsor of the Society for Healthcare Consumer Advocacy 2Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 2Health News:CancerCare(R) and the Tic Tac(R) Brand Attempt To Set a World Record in Times Square 3Health News:Profiles International Releases New Study Identifying Key Factors for Strategic Workforce Planning 2Health News:Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose 2Health News:Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose 3Health News:Laurence Barsh, DMD, Founder of Snoring Isn't Sexy, LLC Emphasizes Need to Evaluate and Treat Sleep Patients 2
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: